Cabel asked "What is the likelyhood of RVX knowing the number of patient years BETonMACE is currently at ...?"

Those chances are pretty good in my opinion. Resverlogix likely knows detailed enrollment and dropout data that would allow them to calculate patient year status. As an example, Resverlogix made the statement below about a year ago. They would need number of events and number of patient years to express an event per 100 patient years figure. Since the trial is blinded, this includes all patient and we don't know the apabetalone/placebo split. As to who they share this info with (i.e. Hepalink, etc.) I don't know. 

BearDownAZ

"Projected primary MACE rate still 8.0 per 100 patient years on top of aggressive standard of care = strong unmet need"